TS

Tal Shapira

Chief Executive Officer at TripleW

Antwerp, Flemish Region

Invests in

Stages:

Locations:

  • Min Investment:

    $5,000.00
  • Max Investment:

    $50,000.00
  • Target Investment:

    $25,000.00

Education

Work Experience

  • Chief Executive Officer

    2019

  • Chief Technology Officer

    2016 - 2019

  • Executive Board Member

    2020 - 2023

    The Blue (theblue.org.il) is a non-for-profit association of football fans, who own the legendary football club Hapoel Petach Tikva FC. Since 1935, the club has inspired generations of Israelis on sports and education in the metropolitan area of Petach Tikva. After years of steady decline, the club was purchased in 2019 by the fans association in order to bring back its heritage of taking care of Petach Tikva's youth, with an embracing educational framework. The association works with dozens of volunteers performing community organization, addressing issues of education and well-being. In April of 2020, 2021, and 2022 I was elected by the fans to the executive board. In the football season of 2022/2023 the club was promoted to the Israeli Premier League.

  • Licensing Director

    2013 - 2016

    Responsible for commercialization of technologies in the fields of renewable energy, microbiology, agriculture, food and research tools. Successfully negotiated licensing deals with multiple multi-national companies. Responsible for monitoring innovation on campus and establishing industry-academia efforts funded by Israeli Innovation Authority (IIA).

2012 - 2013

  • Business Development

    2012 - 2013

    Responsible for drafting and execution of online marketing campaigns, client management and retention. Promodity was sold to Algomizer (TASE:ALMO).

2012 - 2013

  • Business Development Consultant

    2012 - 2013

    Developed scientific collaborations with molecular biology research labs worldwide, testing novel research tools in the field of protein translation.

2010 - 2012

  • Co-founder

    2010 - 2012

    Raised seed capital, developed initial IP portfolio, negotiated IP license agreements with international research institutions and companies. QD developed devices for point of care medical diagnostics.

  • Researcher

    2008 - 2011

    Researched antibiotics synergism in pathogenic bacterial models

  • Lecturer

    2008 - 2010

    Science education for youth, and popular science lectures for adults at the Weizmann Institute of Science

2006 - 2008

  • Private tutor

    2006 - 2008

    Taught chemistry, biology and math for high school and first year undergrads.

2003 - 2005

  • Journalist

    2003 - 2005

    Covered world sports in the daily sports section